(Q39273708)

10 September 2017

title

Enhanced inhibition of foot-and-mouth disease virus by combinations of porcine interferon-α and antiviral agents (English)

1 reference

10 September 2017

main subject

foot-and-mouth disease

1 reference

foot-and-mouth disease virus

inferred from title

object named as

foot-and-mouth disease virus

1 reference

2

Jong-Hyeon Park

1 reference

10 September 2017

Su-Mi Kim

1

1 reference

10 September 2017

Kwang-Nyeong Lee

3

1 reference

10 September 2017

Se-Kyung Kim

4

1 reference

10 September 2017

Young-Joon Ko

5

1 reference

10 September 2017

Hyang-Sim Lee

6

1 reference

10 September 2017

In-Soo Cho

7

1 reference

10 September 2017

publication date

21 September 2012

1 reference

10 September 2017

1 reference

10 September 2017

volume

96

1 reference

10 September 2017

issue

2

1 reference

10 September 2017

page(s)

213-220

1 reference

Molecular epidemiology of foot-and-mouth disease virus.

10 September 2017

cites work

1 reference

12 December 2020

Nucleotide sequence homology requirements of HIV-1-specific short hairpin RNA

1 reference

12 December 2020

Inhibition of foot-and-mouth disease virus replication by small interfering RNA.

1 reference

12 December 2020

Inhibition of human coronavirus NL63 infection at early stages of the replication cycle

1 reference

12 December 2020

Lethal mutagenesis of foot-and-mouth disease virus involves shifts in sequence space

1 reference

12 December 2020

Novel viral disease control strategy: adenovirus expressing alpha interferon rapidly protects swine from foot-and-mouth disease

1 reference

12 December 2020

Adenovirus-mediated RNA interference against foot-and-mouth disease virus infection both in vitro and in vivo

1 reference

12 December 2020

The leader proteinase of foot-and-mouth disease virus negatively regulates the type I interferon pathway by acting as a viral deubiquitinase

1 reference

12 December 2020

Involvement of activation of PKR in HBx-siRNA-mediated innate immune effects on HBV inhibition

1 reference

12 December 2020

Enhanced antiviral activity against foot-and-mouth disease virus by a combination of type I and II porcine interferons

1 reference

12 December 2020

Foot-and-mouth disease virus mutant with decreased sensitivity to ribavirin: implications for error catastrophe

1 reference

12 December 2020

Mechanisms of action of ribavirin against distinct viruses

1 reference

12 December 2020

Current treatment for chronic hepatitis C virus/HIV-infected individuals: the role of pegylated interferon-alpha and ribavirin

1 reference

12 December 2020

Structure of Foot-and-Mouth Disease Virus Mutant Polymerases with Reduced Sensitivity to Ribavirin

1 reference

12 December 2020

Multiple shRNAs driven by U6 and CMV promoter enhances efficiency of antiviral effects against foot-and-mouth disease virus

1 reference

12 December 2020

Evolution of foot-and-mouth disease virus

1 reference

12 December 2020

Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: Use in emergency outbreak response

1 reference

12 December 2020

In vitro inhibition of Chikungunya and Semliki Forest viruses replication by antiviral compounds: synergistic effect of interferon-alpha and ribavirin combination

1 reference

12 December 2020

Curing of foot-and-mouth disease virus from persistently infected cells by ribavirin involves enhanced mutagenesis.

1 reference

12 December 2020

Foot-and-mouth disease

1 reference

12 December 2020

Antiviral therapy for adenovirus infections.

1 reference

12 December 2020

Potential benefits of sequential inhibitor-mutagen treatments of RNA virus infections

1 reference

12 December 2020

Ribavirin cures cells of a persistent infection with foot-and-mouth disease virus in vitro

1 reference

12 December 2020

Characterization of the nucleoside triphosphatase activity of poliovirus protein 2C reveals a mechanism by which guanidine inhibits poliovirus replication

1 reference

12 December 2020

Guanidine and heat sensitivity of foot-and-mouth disease virus (FMDV) strains

1 reference

12 December 2020

RNA interference targeting VP1 inhibits foot-and-mouth disease virus replication in BHK-21 cells and suckling mice

1 reference

12 December 2020

The leader proteinase of foot-and-mouth disease virus inhibits the induction of beta interferon mRNA and blocks the host innate immune response

1 reference

12 December 2020

Mutagenesis versus Inhibition in the Efficiency of Extinction of Foot-and-Mouth Disease Virus

1 reference

12 December 2020

Dynamics of picornavirus RNA replication within infected cells

1 reference

12 December 2020

A Multi-Step Process of Viral Adaptation to a Mutagenic Nucleoside Analogue by Modulation of Transition Types Leads to Extinction-Escape

1 reference

12 December 2020

Alpha/beta interferon protects adult mice from fatal Sindbis virus infection and is an important determinant of cell and tissue tropism

1 reference

12 December 2020

Recombination and oligonucleotide analysis of guanidine-resistant foot-and-mouth disease virus mutants

1 reference

12 December 2020

Antiviral action and selectivity of 6-azauridine

1 reference

12 December 2020

Sequence homology required by human immunodeficiency virus type 1 to escape from short interfering RNAs.

1 reference

12 December 2020

Effect of actinomycin D and guanidine on the formation of a ribonucleic acid polymerase induced by foot-and mouth-disease virus and on the replication of virus and viral ribonucleic acid

1 reference

12 December 2020

Towards the design of combination therapy for the treatment of enterovirus infections

1 reference

12 December 2020

Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays

1 reference

12 December 2020

Inhibition of L-deleted foot-and-mouth disease virus replication by alpha/beta interferon involves double-stranded RNA-dependent protein kinase

1 reference

12 December 2020

Ability of foot-and-mouth disease virus to form plaques in cell culture is associated with suppression of alpha/beta interferon.

1 reference

12 December 2020

10.1016/J.ANTIVIRAL.2012.09.009

Identifiers

DOI

1 reference

10 September 2017

0 references

1 reference